Quest Diagnostics (DGX) Acquisitions (2009 - 2026)

Quest Diagnostics (DGX) has 17 years of Acquisitions data on file, last reported at $38.0 million in Q1 2026.

• Quarterly Acquisitions changed N/A year-over-year to $38.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139.0 million (down 77.97% YoY) and the FY2025 annual result came in at $101.0 million, down 95.33% from the prior year.
• Acquisitions retreated to $38.0 million in Q1 2026 per DGX's latest filing, from $50.0 million in the prior quarter.
• The five-year high for Acquisitions was $578.0 million in Q2 2023, with the low at $1.0 million in Q2 2022.
• Average Acquisitions over 5 years is $130.4 million, with a median of $44.0 million recorded in 2022.
• Year-over-year, Acquisitions sank 99.57% in 2022 and jumped 57700.0% in 2023.
• Quest Diagnostics' Acquisitions stood at $38.0 million in 2022, then plunged by 94.74% to $2.0 million in 2023, then surged by 19050.0% to $383.0 million in 2024, then sank by 86.95% to $50.0 million in 2025, then declined by 24.0% to $38.0 million in 2026.
• Business Quant data shows DGX's Acquisitions at $38.0 million in Q1 2026, $50.0 million in Q4 2025, and $34.0 million in Q3 2025.